Lincomycin

Back to search

Molecule Structure

Scientific Name

Lincomycin

Description of the Drug

Lincomycin is an antibiotic indicated only for the treatment of serious infections and is typically reserved for use in cases of penicillin allergy or where penicillin is inappropriate.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01627

Brand Name(s)

Not Available

Company Owner(s)

Micro Labs Ltd, Watson Laboratories Inc, Praxgen Pharmaceuticals Llc, Xgen Pharmaceuticals Djb Inc, Pfizer Inc, Pharmacia And Upjohn Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
70S ribosome PROTEIN NUCLEIC-ACID COMPLEX INHIBITOR CHEMBL2363853
Bacterial 70S ribosome PROTEIN NUCLEIC-ACID COMPLEX INHIBITOR CHEMBL2363135

Unichem Links

Atlas lincomycin
SureChEMBL SCHEMBL4010
DrugBank DB01627
PubChem: Thomson Pharma 24702559
PubChem 3000540
Mcule MCULE-4676929559
NMRShiftDB 60027594
LINCS LSM-5602
Nikkaji J22.137F
PDBe 3QB
BindingDB 50335522
EPA CompTox Dashboard DTXSID3023215
DrugCentral 1582
Metabolights MTBLC6472
Brenda 30146 40359
Guide to Pharmacology 10941
rxnorm LINCOMYCIN HYDROCHLORIDE LINCOMYCIN LINCOCIN
KEGG Ligand C06812
ChEBI 6472
ZINC ZINC000003982483